AMPH
Amphastar PNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$945.70M
P/E Ratio
10.14
EPS
$2.03
Beta
0.91
52W High
$31.26
52W Low
$17.03
50-Day MA
$23.47
200-Day MA
$25.23
Dividend Yield
—
Profit Margin
13.60%
Forward P/E
—
PEG Ratio
2.77
About Amphastar P
Amphastar Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company is headquartered in Rancho Cucamonga, California.
Fundamentals
| Revenue (TTM) | $719.89M |
| Gross Profit (TTM) | $356.06M |
| EBITDA | $220.20M |
| Operating Margin | 19.50% |
| Return on Equity | 12.90% |
| Return on Assets | 6.37% |
| Revenue/Share (TTM) | $15.40 |
| Book Value | $17.28 |
| Price-to-Book | 1.18 |
| Price-to-Sales (TTM) | 1.31 |
| EV/Revenue | 1.808 |
| EV/EBITDA | 6.13 |
| Quarterly Earnings Growth (YoY) | -31.00% |
| Quarterly Revenue Growth (YoY) | -1.80% |
| Shares Outstanding | $45.37M |
| Float | $34.12M |
| % Insiders | 25.17% |
| % Institutions | 76.61% |
Analyst Ratings
Consensus ($29.00 target)
1
Strong Buy2
Buy4
HoldData last updated: 4/7/2026